Position in ABBV
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$521,306,130
+$75,184,204 QoQ
Shares Held
2,396,920
+22.8% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Swedbank AB holds $4,916,192,999 across 10 Drug Manufacturers - General names. ABBV ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,616,304 | $1,486,627,929 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,091,711 | $853,061,915 | |
| 3 | JNJ |
Johnson & Johnson
|
2,921,146 | $714,044,927 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,396,920 | $521,306,130 | |
| 5 | AZN |
Astrazeneca PLC
|
2,468,411 | $486,820,016 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,398,000 | $334,209,259 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,961,679 | $179,625,830 | |
| 8 | PFE |
Pfizer Inc
|
6,150,865 | $172,716,287 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $521,306,130 | 2,396,920 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $446,121,926 | 1,952,479 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $454,619,527 | 1,963,460 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $356,887,675 | 1,922,679 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $350,592,859 | 1,972,948 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $424,014,441 | 2,147,126 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $367,106,999 | 2,140,316 | Shares | Defined | 2024-07-11 | |
| 2023-12-31 | $288,940,944 | 1,864,496 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $273,776,415 | 1,836,686 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $239,637,109 | 1,778,647 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $270,371,682 | 1,696,503 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $264,927,918 | 1,639,304 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $213,008,314 | 1,587,127 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $202,359,586 | 1,321,230 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $183,932,437 | 1,134,615 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $151,171,662 | 1,116,482 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $116,555,476 | 1,080,518 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $110,018,191 | 976,724 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $97,946,783 | 905,071 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||